恶性肿瘤患者全身18F-FDG PET/CT快速扫描的可行性研究

A feasibility study of rapid whole-body 18F-FDG PET/CT scanning in oncology patients

  • 摘要:
    目的 研究VIP Record采集模式下恶性肿瘤患者全身18F-氟脱氧葡萄糖(FDG) PET/CT快速扫描的可行性。
    方法 回顾性分析2021年10月至2023年8月于天津市人民医院采用VIP Record采集模式行18F-FDG PET/CT全身断层显像的40例恶性肿瘤患者的影像资料,其中男性17例、女性23例,年龄(65.5±10.0)岁、范围42~85岁。以120 s/床位为“金标准”,对原始数据进行重建,获取90 s/床位、60 s/床位、30 s/床位PET/CT图像,对不同扫描时间图像的质量、病灶检出情况、靶本底比值(T/B)进行评估。符合正态分布的计量资料的组间比较采用重复测量方差分析;不符合正态分布的计量资料的组间比较采用秩和检验。
    结果 120 s/床位、90 s/床位、60 s/床位、30 s/床位的图像质量评分分别为3.0(3.0,3.0)、3.0(3.0,3.0)、2.0(2.0,2.0)、1.0(1.0,1.0)分,差异有统计学意义(χ2=108.00,P<0.001);120 s/床位、90 s/床位、60 s/床位的图像质量评分均高于30 s/床位,差异均有统计学意义(Z=−2.43、−2.28、−1.30,均P<0.001);120 s/床位、90 s/床位的图像质量评分均高于60 s/床位,差异均有统计学意义(Z=−1.13、−0.98,均P<0.001);120 s/床位图像质量评分与90 s/床位相当,差异无统计学意义(Z=−0.15, P=0.603)。120 s/床位采集的PET/CT图像共检出136个病灶,90 s/床位、60 s/床位PET/CT图像均全部检出,检出率均为100%(136/136);30 s/床位PET/CT图像共检出134个病灶,检出率为98.5%(134/136)。30 s/床位、60 s/床位、90 s/床位图像的T/B分别为4.09±2.62、4.12±2.46、4.11±2.48,与120 s/床位图像(T/B=4.14±2.49)比较,差异无统计学意义(F=0.22,P=0.885)。
    结论 60 s/床位或30 s/床位采集方案联合120 s/床位肝脏局部加扫可以实现恶性肿瘤患者全身18F-FDG PET/CT的快速扫描显像,具有技术可行性。

     

    Abstract:
    Objective  To investigate the feasibility of whole-body 18F-fluorodeoxyglucose (FDG) PET/CT rapid scanning in patients with malignant tumors using the VIP Record acquisition mode.
    Methods  Imaging data of 40 patients with malignant tumors who underwent whole-body 18F-FDG PET/CT using the VIP Record acquisition mode at Tianjin Union Medical Center from October 2021 to August 2023 were retrospectively analyzed, including 17 males and 23 females, aged (65.5±10.0) years, with an age range of 42–85 years. Utilizing 120 s/bed as the "gold standard", we reprocessed the original data to generate PET/CT images at 90 s/bed, 60 s/bed, and 30 s/bed. Then, we assessed the image quality, lesion detectability, and target-to-background ratio (T/B) across different scan durations. Repeated measures ANOVA should be used to compare measurement data among groups that conform to a normal distribution. For measurement data that do not conform to a normal distribution, the rank-sum test should be used.
    Results  The image quality scores for 120 s/bed, 90 s/bed, 60 s/bed, and 30 s/bed had image quality scores of 3.0 (3.0, 3.0), 3.0 (3.0, 3.0), 2.0 (2.0, 2.0), and 1.0 (1.0, 1.0) points, respectively, and the difference was statistically significant (χ2=108.00, P<0.001). By contrast, the image quality scores for 120 s/bed, 90 s/bed, and 60 s/bed were all higher than those for 30 s/bed, and the differences were statistically significant (Z=−2.43, −2.28, −1.30, all P<0.001). The image quality scores for 120 s/bed and 90 s/bed were higher than those for 60 s/bed, and the differences were statistically significant (Z=−1.13, −0.98, both P<0.001). The image quality score of 120 s/bed was comparable to that of 90 s/bed, and the difference was not statistically significant (Z=−0.15, P=0.603). A total of 136 lesions were identified on PET/CT images acquired at the 120 s/bed. The PET/CT images acquired at the 90 s/bed and 60 s/bed detected all lesions, resulting in a 100% (136/136) detection rate. On the contrary, the PET/CT images acquired at the 30 s/bed detected 134 lesions, yielding a detection rate of 98.5% (134/136). The T/B of 30 s/bed, 60 s/bed, and 90 s/bed images were 4.09±2.62, 4.12±2.46, and 4.11±2.48, respectively, compared with the 120 s/bed image (T/B=4.14±2.49), there was no significant difference (F=0.22, P=0.885).
    Conclusion  The technical feasibility of rapid whole-body 18F-FDG PET/CT imaging in patients with malignant tumors can be achieved by combining the 60 s/bed or 30 s/bed acquisition scheme with the 120 s/bed for a focused liver scan.

     

/

返回文章
返回